Press release
Oncolytic Virus Immunotherapy Market to Reach US$ 572.2 Million by 2031, Driven by Advances in Cancer Treatment and Biotech Innovations - Transparency Market Research Inc.
Oncolytic Virus Immunotherapy
The global oncolytic virus immunotherapy market was valued at US$ 110.2 million in 2022 and is expected to expand at a CAGR of 21.1% from 2023 to 2031, reaching US$ 572.2 million by the end of the forecast period. Key factors propelling market growth include advancements in viral vector technology, increasing clinical trials, and growing adoption of combination therapies with immune checkpoint inhibitors
Get Sample PDF Brochure from here: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=44931
Analyst Viewpoint
Analysts anticipate robust growth in the oncolytic virus immunotherapy market due to increasing R&D activities, strategic collaborations among pharmaceutical companies, and the development of novel therapeutic candidates. However, challenges such as manufacturing complexities and stringent regulatory pathways may slow down market penetration.
Market Demand and Key Drivers
Rising Cancer Prevalence: The increasing global cancer burden is driving demand for innovative treatment modalities.
Advancements in Viral Engineering: Improved genetic modifications enhance virus targeting and effectiveness.
Growing Adoption of Combination Therapies: Synergistic effects with checkpoint inhibitors and chemotherapy boost treatment efficacy.
Favorable Regulatory Approvals: Accelerated approvals and orphan drug designations support market expansion.
Expanding Investment in Immuno-oncology: Increased funding for cancer research fosters new therapeutic developments.
Recent Developments
2022, Amgen: Expanded clinical trials for its oncolytic virus therapy, T-VEC, in combination with checkpoint inhibitors.
2023, Replimune Group: Announced positive Phase II results for its oncolytic virus-based melanoma treatment.
2023, Oncorus: Launched a new platform for intravenously administered oncolytic viral therapies.
2024, SillaJen: Partnered with major biotech firms to develop novel oncolytic virotherapies.
2024, Bristol-Myers Squibb: Acquired an emerging biotech company specializing in oncolytic virus platforms.
Key Market Players
Merck & Co., Inc. (Viralytics Limited)
Amgen Inc.
Shanghai Sunway Biotech Co., Ltd.
TILT Biotherapeutics
Oncorus, Inc.
Replimune Group, Inc.
Oncolys Biopharma, Inc.
Sorrento Therapeutics, Inc.
Oncolytics Biotech, Inc.
SillaJen, Inc.
Visit our report to discover essential insights and analysis - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=44931
Market Trends and Opportunities
Increasing Interest in Personalized Oncolytic Therapies: Tailoring treatments based on tumor genetics.
Integration with Artificial Intelligence: AI-driven discovery for optimized viral design.
Expansion in Emerging Markets: Rising healthcare investments in Asia-Pacific and Latin America.
Development of Multi-Targeting Oncolytic Viruses: Enhancing efficacy through dual-action mechanisms.
Collaboration Between Pharma and Biotech Firms: Driving innovation and accelerated commercialization.
Market Segmentation
By Virus Type:
Herpes Simplex Virus (HSV)
Adenovirus
Reovirus
Newcastle Disease Virus (NDV)
Others
By Application:
Melanoma
Breast Cancer
Lung Cancer
Glioblastoma
Others
By End-User:
Hospitals
Cancer Research Centers
Biotech & Pharmaceutical Companies
Regional Analysis
North America: Strong regulatory support and high adoption of advanced therapies drive growth.
Europe: Increasing government funding and clinical trials boost market expansion.
Asia-Pacific: Growing prevalence of cancer and rising healthcare expenditures propel demand.
Latin America & Middle East/Africa: Improving access to innovative treatments supports market growth.
Future Market Analysis
The oncolytic virus immunotherapy market is poised for rapid expansion, fueled by advancements in virotherapy, increasing collaborations, and rising demand for alternative cancer treatments. The integration of AI in drug discovery, coupled with a focus on combination therapies, is expected to revolutionize the market landscape. Companies investing in next-generation viral immunotherapies will gain a competitive edge in this evolving industry.
Explore Latest Research Reports by Transparency Market Research:
Healthcare Biometrics Market: https://www.pharmiweb.com/press-release/2025-03-12/healthcare-biometrics-market-to-surpass-us-7408-billion-by-2035-driven-by-advancements-in-security-digital-health-solutions-tmr-insights
Healthcare Contract Research Outsourcing Market: https://www.pharmiweb.com/press-release/2025-03-12/healthcare-contract-research-outsourcing-market-to-surpass-us-6309-billion-by-2035-driven-by-increasing-demand-for-cost-effective-drug-development
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact Us:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Oncolytic Virus Immunotherapy Market to Reach US$ 572.2 Million by 2031, Driven by Advances in Cancer Treatment and Biotech Innovations - Transparency Market Research Inc. here
News-ID: 3939007 • Views: …
More Releases from Transparency Market Research
Global Solar Powered Agricultural Dryer Market to Exceed USD 2.4 Billion by 2031 …
The global solar powered agricultural dryer market, valued at US$ 1.6 billion in 2022, is projected to grow at a CAGR of 5.8% from 2023 to 2031, reaching US$ 2.4 billion by the end of 2031. Rising investments in renewable energy, growing awareness of sustainable agricultural practices, and the rapid expansion of the agricultural sector driven by population growth are key factors fueling market growth.
Uncover essential discoveries and trends from…
Technetium-99m Market Forecast 2034: Rising Demand for Diagnostic Imaging and Ra …
The global Technetium‐99m Market was valued at US$ 6.0 Billion in 2023 and is projected to grow at a CAGR of 3.3% from 2024 to 2034, surpassing US$ 8.6 Billion by the end of the forecast period. Advancements in nuclear imaging infrastructure, government-backed healthcare initiatives, and an increasing demand for precise diagnostic procedures are fueling this growth.
Discover essential conclusions and data from our Report in this sample -
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=77100
Analysts' Viewpoint
The Technetium‐99m…
Equine Diagnostic Services Market Outlook 2030: From US$ 168 Million in 2019 to …
The global Equine Diagnostic Services Market, valued at approximately US$ 168 million in 2019, is projected to expand at a compound annual growth rate (CAGR) of ~5% from 2020 to 2030, reaching around US$ 280 million by 2030. Equine diagnostic services, encompassing tests like genetic, infectious disease, and imaging diagnostics, are critical for managing horse health in veterinary hospitals, clinics, and mobile settings. The market is driven by increasing equine…
Digital Printing Market to Reach USD 54.4 Billion by 2034, Growing at a CAGR of …
The digital printing market is experiencing strong growth, driven by rapid technological advancements, rising demand for personalized and on-demand printing, and an increasing focus on sustainable solutions. Digital printing allows for the direct transfer of digital files onto a wide range of substrates, offering high-resolution output with greater speed and flexibility. Its adaptability has led to broad adoption across industries such as packaging, textiles, publishing, and advertising-sectors where customization, efficiency,…
More Releases for Oncolytic
Prominent Oncolytic Virus Therapy Market Trend for 2025: Accelerating Oncolytic …
Which drivers are expected to have the greatest impact on the over the oncolytic virus therapy market's growth?
The rise in cancer incidences is likely to fuel the expansion of the oncolytic virus therapy market. Oncolytic virus therapy is gaining traction as an appealing approach to treating cancer- a collection of diseases marked by abnormal cell growth and proliferation. This therapeutic strategy effectively targets and eliminates cancer cells, while also triggering…
Enhancing the Immune Response with Oncolytic Virus Therapy
Oncolytic virus therapy is revolutionizing cancer treatment by harnessing the unique characteristics of viruses to specifically target and destroy cancer cells. This cutting-edge approach represents a significant advancement in cancer care, offering renewed hope for patients with different types of cancer.
Download Report:
https://www.kuickresearch.com/report-oncolytic-virus-immunotherapy-market-oncolytic-virus-therapy-market-oncolytic-virus-fda-approved-oncolytic-virus-clinical-trilas
The essence of oncolytic virus therapy is based on genetically modified viruses that can selectively attack and kill cancer cells while leaving healthy tissue unharmed. These engineered viruses take…
Creative Biolabs Unleashes Solutions to Validate Oncolytic Virotherapy
Creative Biolabs introduces safety and efficacy validation strategies for oncolytic virotherapy.
New York, USA - June 17, 2024 - Oncolytic virotherapy appears as a new paradigm in cancer immunotherapy that enrolls specifically engineered viruses to selectively infect and kill cancer cells, some of which have marched into clinical trials, like adenoviruses, HSV, reovirus, vaccinia virus, and measles. With so many other candidates still on their preclinical journey, the requests to validate…
Oncolytic Virus Competitive Landscape 2023 (Updated)
DelveInsight's, "Oncolytic Virus Competitive Landscape 2023" report provides comprehensive insights about 150+ Oncolytic Virus Companies and 175+ drugs in the Oncolytic Virus Competitive landscape. It covers the Oncolytic Virus therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Oncolytic Virus Competitive Landscape Report
• DelveInsight's Oncolytic Virus report depicts a robust space with 150+ Oncolytic…
Oncolytic Virus Therapy Market Oncolytic Virus Therapy Clinical Pipeline Report …
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
Prologue to Oncolytic Virus
1.1 Outline of Oncolytic Virotherapy
1.2 Trail from Genesis to Biogenetics
Primer of Virotherapy in Malignancies
2.1 Oncolytic Viruses towards Cancer
2.2 Approaches for Targeting Tumor Cells
2.2.1 Pro Apoptotic Targeting
2.2.2 Translational Targeting
2.2.3 Transcriptional Targeting
2.2.4 Transductional Targeting
Mechanism…
Global Oncolytic Virus Therapy Report Highlight Market Opportunity & Insight On …
“Global Oncolytic Virus Therapy Market and Pipeline Outlook 2022” report analyzes ongoing clinical and non-clinical trends in the oncolytic virus therapy market. Currently there are 2 oncolytic virus therapies commercially available in the market. This report analyzes the ongoing clinical trial of 48 oncolytic virus therapies in clinical pipeline and gives comprehensive clinical insight on various parameters associated with the development of the oncolytic virus therapies. Most of the oncolytic…
